Related references
Note: Only part of the references are listed.Glycation and biomarkers of vascular complications of diabetes
Paul J. Beisswenger
AMINO ACIDS (2012)
CA 19-9 Level in Patients With Type 2 Diabetes Mellitus and Its Relation to the Metabolic Control and Microvascular Complications
Kamile Gul et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2011)
The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study
Tse-Min Lu et al.
CARDIOVASCULAR DIABETOLOGY (2011)
Personalized Medicine in Diabetes
Noemi Malandrino et al.
CLINICAL CHEMISTRY (2011)
Nontraditional Markers of Glycemia Associations with microvascular conditions
Elizabeth Selvin et al.
DIABETES CARE (2011)
Association of the C47T polymorphism in SOD2 with diabetes mellitus and diabetic microvascular complications: a meta-analysis
C. Tian et al.
DIABETOLOGIA (2011)
Relationships among Diabetic Retinopathy, Antioxidants, and Glycemic Control
Carly S. Y. Lam et al.
OPTOMETRY AND VISION SCIENCE (2011)
Glyoxalase in diabetes, obesity and related disorders
Naila Rabbani et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2011)
Association analysis of nine candidate gene polymorphisms in Indian patients with type 2 diabetic retinopathy
Suganthalakshmi Balasubbu et al.
BMC MEDICAL GENETICS (2010)
SLC2A10 genetic polymorphism predicts development of peripheral arterial disease in patients with type 2 diabetes. SLC2A10 and PAD in type 2 diabetes
Yi-Der Jiang et al.
BMC MEDICAL GENETICS (2010)
Perturbations in the lipid profile of individuals with newly diagnosed type 1 diabetes mellitus: Lipidomics analysis of a Diabetes Antibody Standardization Program sample subset
Christina M. Sorensen et al.
CLINICAL BIOCHEMISTRY (2010)
Urinary matrix metalloproteinase-8 and-9 activities in type 2 diabetic subjects: A marker of incipient diabetic nephropathy?
Nynke J. van der Zijl et al.
CLINICAL BIOCHEMISTRY (2010)
The Emerging Role of Biomarkers in Diabetic and Hypertensive Chronic Kidney Disease
Kunal Chaudhary et al.
CURRENT DIABETES REPORTS (2010)
Evaluation of Serum 1,5 Anhydroglucitol Levels as a Clinical Test to Differentiate Subtypes of Diabetes
Aparna Pal et al.
DIABETES CARE (2010)
Osteoprotegerin and Mortality in Type 2 Diabetic Patients
Henrik Reinhard et al.
DIABETES CARE (2010)
Proteomic Identification of Human Urinary Biomarkers in Diabetes Mellitus Type 2
Samreen Riaz et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2010)
Urinary biomarkers involved in type 2 diabetes: a review
Agnes Matheson et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2010)
Lipid and inflammatory biomarkers and kidney function decline in type 2 diabetes
J. Lin et al.
DIABETOLOGIA (2010)
Association of vascular endothelial growth factor-634C/G polymorphism and diabetic retinopathy in type 2 diabetic Han Chinese
Ying Yang et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2010)
Genetic Variants of the Protein Kinase C-β1 Gene and Development of End-Stage Renal Disease in Patients With Type 2 Diabetes
Ronald C. W. Ma et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Glycation Isotopic Labeling with 13C-Reducing Sugars for Quantitative Analysis of Glycated Proteins in Human Plasma
Feliciano Priego-Capote et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Proteomic approaches for discovering biomarkers of diabetic nephropathy
Randa Ben Ameur et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Association of ADIPOQ genetic variants and plasma adiponectin isoforms with the risk of incident renal events in type 2 diabetes
Riphed Jaziri et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Advanced glycation end products, oxidative stress and diabetic nephropathy
Sho-ichi Yamagishi et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2010)
Oxidative stress: A cause and therapeutic target of diabetic complications
Eiichi Araki et al.
JOURNAL OF DIABETES INVESTIGATION (2010)
Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy
Masayoshi Takeuchi et al.
JOURNAL OF OPHTHALMOLOGY (2010)
Time for new guidelines in advanced diabetes care: Paradigm change from delayed interventional approach to predictive, preventive & personalized medicine
Olga Golubnitschaja
EPMA JOURNAL (2010)
Emerging roles of cardiolipin remodeling in mitochondrial dysfunction associated with diabetes, obesity, and cardiovascular diseases
Yuguang Shi
JOURNAL OF BIOMEDICAL RESEARCH (2010)
Metabolomics Applied to Diabetes Research Moving From Information to Knowledge
James R. Bain et al.
DIABETES (2009)
Development of a Type 2 Diabetes Risk Model From a Panel of Serum Biomarkers From the Inter99 Cohort
Janice A. Kolberg et al.
DIABETES CARE (2009)
Evaluation of Urinary Biomarkers for Coronary Artery Disease, Diabetes, and Diabetic Kidney Disease
Janet K. Snell-Bergeon et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2009)
Urinary Peptidome May Predict Renal Function Decline in Type 1 Diabetes and Microalbuminuria
Michael L. Merchant et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Neutrophil Gelatinase-Associated Lipocalin as an Early Biomarker of Nephropathy in Diabetic Patients
Davide Bolignano et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2009)
The Role of Inflammatory Cytokines in Diabetes and Its Complications
George L. King
JOURNAL OF PERIODONTOLOGY (2008)
Urinary proteomics in diabetes and CKD
Kasper Rossing et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
The urinary proteome in diabetes and diabetes-associated complications: New ways to assess disease progression and evaluate therapy
Kasper Rossing et al.
PROTEOMICS CLINICAL APPLICATIONS (2008)
Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy
Hasan H. Otu et al.
DIABETES CARE (2007)
The use of proteomics in identifying differentially expressed serum proteins in humans with type 2 diabetes
Tea Sundsten et al.
PROTEOME SCIENCE (2006)
Prevention and early detection of vascular complications of diabetes
Sally M. Marshall et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Association between PON 1 polymorphisms, PON activity and diabetes complications
Sabine E. Hofer et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2006)
Clinical significance of circulating hepatocyte growth factor, a new risk marker of carotid atherosclerosis in patients with Type 2 diabetes
K. Satani et al.
DIABETIC MEDICINE (2006)
The burden of mortality attributable to diabetes - Realistic estimates for the year 2000
G Roglic et al.
DIABETES CARE (2005)
The pathobiology of diabetic complications - A unifying mechanism
M Brownlee
DIABETES (2005)
Share Paper
